Page 9 - பேரிக்காய் சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பேரிக்காய் சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பேரிக்காய் சிகிச்சை Today - Breaking & Trending Today

Northwell, Pear Therapeutics partner with new treatment for substance-abuse disorders

Get our free LIBN e-alerts & breaking news notifications!
Northwell, Pear Therapeutics partner with new treatment for substance-abuse disorders
By: Adina Genn
April 22, 2021
Comments Off on Northwell, Pear Therapeutics partner with new treatment for substance-abuse disorders
A new FDA-authorized option is available for patients seeking treatment for opioid and substance use disorders. The new treatment, prescription digital therapeutics, or PDTs, is available through a collaboration between Northwell Health in New Hyde Park and Pear Therapeutics, in Boston and San Francisco.
N0rthwell will offer digital care to patients through Pear’s PDTs (there are two products, “reSET” and “reSET-O”) through the substance abuse treatment programs at Zucker Hillside Hospital, Northwell’s behavioral health facility. ....

United States , San Francisco , Bruce Goldman , Julia Strandberg , Northwell Health , New Hyde Park , Pear Therapeutics , Zucker Hillside Hospital , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , காயங்கள் கோல்ட்மேன் , ஜூலியா ஸ்ட்ராண்ட்பெர்க் , நார்த்வெல் ஆரோக்கியம் , புதியது ஹைட் பூங்கா , பேரிக்காய் சிகிச்சை , ஜுக்கேர் மலைப்பகுதி மருத்துவமனை ,

Global Healthtech CEO Connect: Software As A Medical Device In The U.S. And EU Recap | MoFo Life Sciences

To embed, copy and paste the code into your website or blog:
On Friday, March 26, 2021, over 180 attendees worldwide attended McKinsey & Company’s first Global HealthTech CEO Connect of 2021. The discussion focused on regulatory and legal considerations for software as a medical device (SaMD) in both the United States and Europe and specific use cases for digital therapeutics and other digital health products. Speakers included Morrison & Foerster partners Bethany Hills and Wolfgang Schönig as well as special guest Corey McCann, president and CEO of Pear Therapeutics, in a fireside chat at the end of the program.
Globally, the convergence of software technology and life sciences creates a massive opportunity for growth, and the market for these products is growing exponentially. Both the U.S. Food and Drug Administration (FDA) and European regulators have focused on establishing a regulatory framework for oversight of SaMD. ....

United States , Corey Mccann , Morrison Foerster , Eu Commission , International Medical Device Regulators Forum , Health Schemes Di , European Union , Mofo Life Sciences , Mckinsey Company , European Court , German Federal Institute For Drugs , Digital Health Apps , Eligibility Of Digital Health Applications For Reimbursement , Drug Administration , European Commission , Medicare Coverage Of Innovative Technology , Clinical Decision Support Software Guidance , Certification Pilot Program , Mofo Life , Global Healthtech , Bethany Hills , Wolfgang Sch , Pear Therapeutics , Pre Certification Pilot Program , Medicare Coverage , Innovative Technology ,

DTx company Pear inks slew of deals to integrate more digital biomarkers and a digital pill into platform

(Photo by Klaus Vedfelt/Getty Images)
Digital therapeutics company Pear Therapeutics is looking to integrate digital biomarkers, machine learning algorithms and sensor-based technologies into its platform thanks to new licensing deals and partnerships.
The Boston-based DTx company has inked collaboration deals with Empatica and etectRx, as well as licensing tech from KeyWise.
Specifically, Pear s collaboration with Empatica will focus on the use of medical-grade wearables and digital biomarkers. The company is looking to use wearables to evaluate a patient s withdrawal symptoms from opioids, alcohol and other substances.
The etectRx partnership will focus on medication adherence. Pear will now be able to integrate etectRx s digital pill, which can show if a patient ingested the medication. This partnership isn t a surprise. In January, the two companies announced a deal to potentially develop a product that combines the former s DTx with a digital pill offering. ....

Corey Mccann , Pear Therapeutics , கோரி ம்க்க்யாந் , பேரிக்காய் சிகிச்சை ,

Digital therapeutics startup Dthera Sciences was sunk by Alzheimer's drug failures, CMS reimbursement limitations

(Photo by Sebastian Kaulitzki/Getty Images)
Those keeping an eye on the digital therapeutics industry over the last several years likely remember the name Dthera Sciences.
The startup and its CEO Ed Cox became one of the developing space s many standard bearers around 2018. During that timeframe it landed a Breakthrough Device designation from the FDA for its Alzheimer s symptoms treatment, with Cox chairing a handful of industry networking events through the following months.
But despite the regulatory win and initial interest from potential partners, Dthera s momentum petered out in the following years.
Cox – now EVP of strategic alliances and global head of digital medicine at Eversana – told ....

David Keene , Ed Cox , Sebastian Kaulitzki Getty , University Of California San Diego , Technology Association Advamed , Digital Health , Dthera Sciences , Alzheimer Association , Breakthrough Device , Getty Images , Digital Health Today , Introspect Digital Therapeutics , California San Diego , Pear Therapeutic , Breakthrough Status , Advanced Medical Technology Association , Breakthrough Designation , Tokyo Based Eisai , டேவிட் கீந் , எட் காக்ஸ் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா சான் டியாகோ , டிஜிட்டல் ஆரோக்கியம் , முதுமறதி சங்கம் , திருப்புமுனை சாதனம் , கெட்டி படங்கள் , டிஜிட்டல் ஆரோக்கியம் இன்று ,

Pear Therapeutics and Prescryptive Health Announce Formulary Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for the Treatment of Substance and Opioid Use Disorders

Pear Therapeutics and Prescryptive Health Announce Formulary Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for the Treatment of Substance and Opioid Use Disorders
By
Staff
2 seconds ago
Prescryptive Health, a health intelligence platform focused on improving the prescription drug market and the pharmacy experience, teams with Pear to make innovative prescription digital therapeutics (PDTs) accessible to its members in recovery.
Prescryptive Health will offer and administer Pear’s reSET® and reSET-O® through its digital platform as a covered standard pharmacy benefit for people with substance use disorder or opioid use disorder.
BOSTON & SAN FRANCISCO & REDMOND, Wash.–(BUSINESS WIRE)–Pear Therapeutics, Inc. and Prescryptive Health today announced that Prescryptive, the first health intelligence platform, will offer and administer benefit coverage for reSET® and reSET-O®, the first two prescription digital therapeutics (PDTs) ....

Keely Boyer , Ba Fulton Velez , Karren Williams , Robert Gerwien , Weijia Wang , Kirstin Gatchalian , Warrenk Bickel , Yuria Maricich , Chris Blackley , Charles Ruetsch Kathryn Anastassopoulos , Bruce Imbert , Benjamin Parcher , Laura Kauffman , Xiaorui Xiong , Corey Mccann , Hilaryf Luderer , Lisaa Marsch , Stephen Braun , Sam Colman , Nicole Gellings Lowe , Fultonf Velez , Alice Kuo , Prescryptive Health , Journal Of Current Medical Research , Drug Administration , Current Medical Research ,